These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 23305663)

  • 1. Ras GTPases: codon bias holds KRas down but not out.
    Bodemann BO; White MA
    Curr Biol; 2013 Jan; 23(1):R17-20. PubMed ID: 23305663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare codons regulate KRas oncogenesis.
    Lampson BL; Pershing NL; Prinz JA; Lacsina JR; Marzluff WF; Nicchitta CV; MacAlpine DM; Counter CM
    Curr Biol; 2013 Jan; 23(1):70-5. PubMed ID: 23246410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.
    Bentley C; Jurinka SS; Kljavin NM; Vartanian S; Ramani SR; Gonzalez LC; Yu K; Modrusan Z; Du P; Bourgon R; Neve RM; Stokoe D
    Biochem J; 2013 Jun; 452(2):313-20. PubMed ID: 23496764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
    Vaughn CP; Zobell SD; Furtado LV; Baker CL; Samowitz WS
    Genes Chromosomes Cancer; 2011 May; 50(5):307-12. PubMed ID: 21305640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer.
    Netzel BC; Grebe SK
    Clin Chim Acta; 2013 Oct; 425():1-2. PubMed ID: 23832066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pancreatic duct epithelial cell model for KRAS transformation.
    Radulovich N; Qian JY; Tsao MS
    Methods Enzymol; 2008; 439():1-13. PubMed ID: 18374152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
    Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
    Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation bias within oncogene families is related to proliferation-specific codon usage.
    Benisty H; Weber M; Hernandez-Alias X; Schaefer MH; Serrano L
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30848-30856. PubMed ID: 33199641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ¹H, ¹³C and ¹⁵N resonance assignment for the human K-Ras at physiological pH.
    Vo U; Embrey KJ; Breeze AL; Golovanov AP
    Biomol NMR Assign; 2013 Oct; 7(2):215-9. PubMed ID: 22886485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
    Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
    Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
    Huang L; Counter CM
    PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status.
    Modest DP; Stintzing S; Laubender RP; Neumann J; Jung A; Giessen C; Haas M; Aubele P; Schulz C; Boeck S; Stemmler HJ; Kirchner T; Heinemann V
    Anticancer Drugs; 2011 Oct; 22(9):913-8. PubMed ID: 21795973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors.
    Capella G; Cronauer-Mitra S; Pienado MA; Perucho M
    Environ Health Perspect; 1991 Jun; 93():125-31. PubMed ID: 1685441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-mediated regulation of KRAS in cancer.
    Kim M; Slack FJ
    J Hematol Oncol; 2014 Nov; 7():84. PubMed ID: 25433809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare codons capacitate Kras-driven de novo tumorigenesis.
    Pershing NL; Lampson BL; Belsky JA; Kaltenbrun E; MacAlpine DM; Counter CM
    J Clin Invest; 2015 Jan; 125(1):222-33. PubMed ID: 25437878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
    Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
    Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.